Cynthia Bamdad | Chief Executive Officer
Minerva Biotechnologies Corp

Cynthia Bamdad, Chief Executive Officer, Minerva Biotechnologies Corp

Cynthia Bamdad is the CEO of Minerva Biotechnologies. Dr. Bamdad holds a BS in Physics from Northeastern University and a PhD in Biophysics from Harvard University. While a grad student at Harvard, Bamdad invented an electronic DNA chip that sold to Motorola for $300M in 2000, and is now an FDA approved diagnostic device marketed by GenMark. Dr. Bamdad also served on the Board of Directors of Pharmacyclics during their turn-around from near bankruptcy to $1B deal with J&J for 50% of the drug that would become Imbruvica, followed a few years later by a $21B Abbvie acquisition.

Appearances:



Conference Day 1 - Tuesday 31st March 2020 @ 15:20

1st-in-Human CAR T Targets MUC1 Cleavage Product Expressed on Solid Tumors

last published: 05/Dec/19 09:46 GMT

back to speakers